What amount sold does NBOT Labs LLC report in Form D filings?

The latest linked filings report $1M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was NBOT Labs LLC's most recent SEC filing?

NBOT Labs LLC's most recent Form D filing was on 2024-09-09.

How many investors does NBOT Labs LLC have?

The most recent Form D filing lists 1 investor(s).

NBOT Labs LLC

CIK: 0002010058·Biotechnology·MT. PLEASANT, SC·Limited Liability Company·Founded 2021

Reported Sold

$1,000,000

Total Filings

Identified Offerings

Last Filed

Sep 9, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Sep 9, 2024Form D — New notice

Reported sold: $1,000,000 · Target: $1,000,000

Rule 506(c)·1 investor

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

$1 - $1,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$1,000,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Steven Gareleck

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 9, 2024	New	$1,000,000	$1,000,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

511 Therapeutics, Inc.

Biotechnology

Offering target: $1,000,000

Filed Oct 30, 2026